Protein-bound polysaccharide-K (PSK) induces apoptosis via p38 mitogen-activated protein kinase pathway in promyelomonocytic leukemia HL-60 cells

Anticancer Research

Volumn 32, Issue 7, 2012, Pages 2631-2637

  Hirahara, Noriyuki ^a   Edamatsu, Takeo ^b   Fujieda, Ayako ^b   Fujioka, Masaki ^b   Wada, Tsutomu ^b   Tajima, Yoshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b KUREHA CORPORATION   (Japan)

Author keywords

Apoptosis; HL 60 cells; P38MAPK; PSK

Indexed keywords

BETA ACTIN; CASPASE 3; KRESTIN; MITOGEN ACTIVATED PROTEIN KINASE 14; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL STRAIN HL 60; DOWN REGULATION; LEUKEMIA; PRIORITY JOURNAL; PROMYELOMONOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASE 3; CELL DIFFERENTIATION; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; IMIDAZOLES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEOGLYCANS; PYRIDINES;

EID: 84865697267     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K and Orita K: Krestin (PSK). Cancer Treat Rev 11: 131-155, 1984. (Pubitemid 16004444)
2. Nakazato H, Koike A, Saji S, Ogawa N and Sakamoto J: Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 343: 1122-1126, 1994. (Pubitemid 24142032)
3. Ohwada S, Ikeya T, Yokomori T, Kusaba T, Roppongi T, Takahashi T, Nakamura S, Kakinuma S, Iwazaki S, Ishikawa H, Kawate S, Nakajima T and Morishita Y: Adjuvant immunochemotherapy with oral tegafur/uracil plus PSK in patients with stage II or III colorectal cancer: a randomized controlled study. Br J Cancer 90: 1003-1010, 2004. (Pubitemid 38495819)
4. Sakamoto J, Morita S, Oba K, Matsui T, Kobayashi M, Nakazato H and Ohashi Y: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother 55: 404-411, 2006. (Pubitemid 43076892)
5. Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y and Sakamoto J: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother 56: 905-911, 2007. (Pubitemid 46729147)
6. Hayakawa K, Mitsuhashi N, Saito Y, Nakayama Y, Furuta M, Nakamoto S, Kawashima M and Niibe H: Effect of krestin as adjuvant treatment following radical radiotherapy in non-small cell lung cancer patients. Cancer Detect Prev 21: 71-77, 1997. (Pubitemid 27307074)
7. Hirose K, Zachariae CO, Oppenheim JJ and Matsushima K: Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells. Lymphokine Res 9: 475-483, 1990. (Pubitemid 20384838)
8. Harada M, Matsunaga K, Oguchi Y, Iijima H, Tamada K, Abe K, Takenoyama M, Ito O, Kimura G and Nomoto K: Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice. Int J Cancer 70: 362-372, 1997. (Pubitemid 27099608)
9. Kanazawa M, Mori Y, Yoshihara K. Iwadate M, Suzuki S, Endoh Y, Ohki S, Takita K, Sekikawa K and Takenoshita S: Effects of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol Lett 91: 229-238, 2004. (Pubitemid 38296383)
10. Lu H, Yang Y, Gad E, Wenner CA, Chang A, Larson ER, Dang Y, Martzen M, Standish LJ, and Disis ML: Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T-cells and NK cells. Clin Cancer Res 17: 67-76, 2011.
11. Kariya Y, Inoue N, Kihara T, Okamoto N, Sugie K, Mori T and Uchida A: Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon or interleukin 2. Immunol Lett 31: 241-245, 1992.
12. Lu H, Yang Y, Gad E, Inatsuka C, Wenner CA, Disis ML and Standish LJ: TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clin Cancer Res 17: 6742-6753, 2011.
13. Hattori ST, Komatsu N, Shichijo S and Itoh K: Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa. Biomed Pharmacother 58: 226-230, 2004. (Pubitemid 38746748)
14. Jiménez-Medina E, Berruguilla E, Romero I, Algarra I, Collado A, Garrido F and Angel Garcia-Lora: The immunomodulator PSK induces in vitro cytotoxic activity in tumor cell lines via arrest of cell cycle and induction of apoptosis. BMC Cancer doi: 10. 1186/1471-2407-8-78, 2008.
15. Hirahara N, Fujioka M, Edamatsu T, Fujieda A, Sekine F, Wada T and Tanaka T: Protein-bound polysaccharide-K (PSK) induces apoptosis and inhibits proliferation of promyelocytic leukemia HL-60 cells. Anticancer Res 31: 2733-2738, 2011.
16. Hoshi H, Saito H, Iijima H, Uchida M, Wada T, Ito G, Tanaka H and Sawada K: Anti-protein-bound polysaccharide-K monoclonal antibody binds the active structure and neutralizes direct antitumor action of the compound. Oncol Rep 25: 905-913, 2011.
17. Jun CD, Pae HO, Kwak HJ, Yoo JC, Choi BM, Oh CD, Chun JS, Paik SG, Park YH and Chung HT: Modulation of Nitric Oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways. Cell Immunol 194: 36-46, 1999.
18. Kondoh M, Tasaki E, Araragi S, Takiguchi M, Higashimoto M, Watanabe Y and Sato M: Requirement of caspase and p38 MAPK activation in zinc-induced apoptosis in human leukemia HL-60 cells. Eur J Biochem 269: 6204-6211, 2002. (Pubitemid 35461833)
19. Ahn YH, Jung JM and Hong SH: 8-chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells. Cancer Res 65: 4896-4901, 2005. (Pubitemid 40740829)
20. Park SJ and Kim IS: The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukemia HL-60 cells. Br J Pharmacol 146: 506-513, 2005.
21. Martin SJ, Bradley JG and Cotter TG: HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 79: 448-453, 1990. (Pubitemid 20082275)
22. Benito A, Grillot D, Nunez G and Fernandez-Luna JL: Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am J Pathol 146: 481-490, 1995.
23. Westin EH, Wong-Staal F, Gelmann EP, Favera RD, Papas TS, Lautenberger JA, Eva A, Reddy EP, Tronick SR, Aaronson SA and Gallo RC: Expression of cellular homologues of retroviral oncogenes in human hematopoietic cells. Proc Natl Acad Sci USA 79: 2490-2494, 1982.w (Pubitemid 12068394)
24. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA and Della Porta G: BCL-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79: 1291-1298, 1992.
25. Suzuki H, Uchida K, Shima H, Sato T, Okamoto T, Kimura T and Miwa M: Molecular cloning of cDNA for human poly(ADP-ribose) polymerase and expression of its gene during HL-60 cell differentiation. Biochem Biophys Res Commun 146: 403-409, 1987. (Pubitemid 17100884)
26. Torcia M, De Chiara G, Nencioni L, Ammendola S, Labardi D, Lucibello M, Rosini P, Marlier LN, Bonini P, Dello SP, Palamara AT, Zambrano N, Russo T, Garaci E and Cozzolino F: Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of BCL-2 phosphorylation, and cytochrome release. J Biol Chem 276: 39027-39036, 2001.
27. De Chiara G, Marcocci ME, Torcia M, Lucibello M, Rosini P, Bonini P, Higashimoto Y, Damonte G, Armirotti A, Amodei S, Palamara AT, Russo T, Garaci E and Cozzolino F: BCL-2 phosphorylation by p38 MAPK. J Biol Chem 281: 21353-21361, 2006.
28. Riedl SJ and Salvesen GS: The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8: 405-413, 2007. (Pubitemid 46643237)
29. Tait SW and Green DR: Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632, 2010.
30. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P and Zychlinsky A: Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736-739, 1999.
31. Into T, Nodasaka Y, Hasbe A, Okuzawa T, Nakamura J, Ohata N and Shibata K: Mycoplasmal lipoproteins induce toll-like receptor 2- and caspase-mediated cell death in lymphocytes and monocytes. Microbiol Immunol 46: 265-276, 2002. (Pubitemid 34456679)
32. Hasebe A, Yoshimura A, Into T, Kataoka H, Tanaka S, Arakawa S, Ishikura H, Golenbock DT, Sugaya T, Tsuchida N, Kawanami M, Hara Y and Shibata K: Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease. Infect Immun 72: 1318-1325, 2004. (Pubitemid 38263751)
33. Into T, Kiura K, Yasuda M, Kataoka H, Inoue N, Hasebe A, Takeda K, Akira S, Shibata K: Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation. Cell Microbiol 6: 187-199, 2004. (Pubitemid 38111599)
34. Aleman M, Schierloh P, de la Barrera SS, Musella RM, Saab MA, Baldini M, Abbate E and Sasiain MC: Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infect Immun 72: 5150-5158, 2004. (Pubitemid 39223400)
35. Li C, Wang Y, Gao L, Zhang J, Shao J, Wang S, Feng W, Wang X, Li M and Chang Z: Expression of toll-like receptors 2 and 4 and CD14 during differentiation of HL-60 cells induced by phorbol 12-myristate 13-acetate and 1α, 25-dihydroxy-vitamin D3. Cell Growth Differ 13: 27-38, 2002. (Pubitemid 34106797)
36. Shuto T, Furuta T, Cheung J, Gruenert DC, Ohira Y, Shimasaki S, Suico MA, Sato K and Kai H: Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells. Leuk Res 31: 1721-1728, 2007. (Pubitemid 350051411)